Gemcitabine + cisplatin (GP)

DRUG3 trials

Sponsors

Zhejiang University, Sun Yat-sen University

Conditions

Advanced Intrahepatic CholangiocarcinomaNasopharyngeal CancerNasopharyngeal Cancinoma (NPC)

Phase 1

Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma

RecruitingNCT06956716

Zhejiang UniversityAdvanced Intrahepatic Cholangiocarcinoma

Start: 2025-04-09End: 2028-04-01Target: 30Updated: 2025-05-04

Phase 3

Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma

Not yet recruitingNCT07373990

Sun Yat-sen UniversityNasopharyngeal Cancer, Nasopharyngeal Cancinoma (NPC)

Start: 2026-01-15End: 2030-12-31Target: 418Updated: 2026-01-28

Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Not yet recruitingNCT07524413

Sun Yat-sen UniversityNasopharyngeal Cancer, Nasopharyngeal Cancinoma (NPC)

Start: 2026-04-01End: 2032-04-01Target: 514Updated: 2026-04-13